NHPAP - NASDAQ

National Healthcare Properties, Inc.

NHPAP·NASDAQ

$22.38

+0.13%

Real EstateREIT - Healthcare Facilities

National Healthcare Properties, Inc. operates as a real estate investment trust. It operates through the Medical Office Buildings and Senior Housing Operating Properties segments. The company was founded on October 15, 2012 and is headquartered in New York, NY.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$635.75M

EPS-2.5100

P/E Ratio-8.92

Earnings Date08/27/2026

1.71B

Assets

-12%

3Y-21.0%

5Y-25.0%

10Y-22.0%

1.11B

Total Liabilities

-12%

3Y-6.0%

5Y-16.0%

10Y+61.0%

604.52M

Total Equity

-12%

3Y-39.0%

5Y-37.0%

10Y-60.0%

National Healthcare Properties, Inc. Funding & Solvency Profile

NHPAP · NASDAQ

Current Assets

Cash & Cash Equivalents108.45M

Net Receivables30.74M

Inventory0.00

Other Current Assets0.00

Total Current Assets139 M

Non-Current Assets

Property, Plant & Equipment7.38M

Goodwill & Intangible Assets0.00

Long-Term Investments1.52B

Other Non-Current Assets45.81M

Total Non-Current Assets2 B

Total Assets

1.71B

Financial Health Analysis

Current Ratio

0.41x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

1.83x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

-197492000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

8% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

National Healthcare Properties, Inc. Balance Sheet

NHPAP • NASDAQ

National Healthcare Properties, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	108.5M	21.7M	46.4M	53.7M	59.7M	72.4M	95.7M	91.4M	102.6M	33.2M	29.1M	184.4M
Cash & Short-Term Investments	108.5M	21.7M	46.4M	53.7M	59.7M	72.4M	95.7M	91.4M	102.6M	33.2M	29.1M	184.4M
Net Receivables	30.7M	22.8M	26.3M	25.3M	23.9M	23.3M	21.2M	17.4M	15.3M	12M	11.5M	6K
Accounts Receivables	30.7M	22.8M	26.3M	25.3M	23.9M	23.3M	21.2M	0.0	0.0	0.0	0.0	0.0
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4M	15.3M	12M	11.5M	6K
Prepaids	0.0	0.0	0.0	34.6M	32.6M	34.9M	39.7M	0.0	0.0	0.0	0.0	0.0
Other Current Assets	0.0	52.4M	44.9M	-11.7M	-6.9M	-16.9M	47M	-108.7M	-117.9M	-45.2M	-40.6M	-184.4M
Total Current Assets	139.2M	96.9M	117.6M	101.8M	109.2M	113.8M	203.6M	0.0	0.0	0.0	0.0	0.0
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	7.4M	7.5M	7.7M	7.8M	7.9M	13.9M	14.4M	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	55.4M	26.3M	25.3M	23.9M	23.3M	21.2M	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	0.0	55.4M	293.3M	292M	288.4M	276M	269.6M	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	1.5B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	45.8M	1.8B	1.7B	1.8B	1.8B	1.9B	1.8B	0.0	0.0	0.0	0.0	0.0
Total Non-Current Assets	1.6B	1.8B	2B	2.1B	2.1B	2.2B	2.1B	0.0	0.0	0.0	0.0	0.0
Other Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4B	2.4B	2.2B	2.3B	1.9B
Total Assets	1.7B	1.9B	2.1B	2.2B	2.2B	2.3B	2.3B	2.4B	2.4B	2.2B	2.3B	1.9B
LIABILITIES
CURRENT LIABILITIES
Total Payables	44.4M	93.1M	51.9M	48.7M	46.1M	43M	50M	0.0	0.0	0.0	0.0	0.0
Accounts Payable	44.4M	89.6M	48.4M	45.2M	42.7M	42.3M	43.1M	0.0	0.0	0.0	0.0	0.0
Other Payables	0.0	3.5M	3.5M	3.5M	3.4M	742K	6.9M	0.0	0.0	0.0	0.0	0.0
Short Term Debt	336.7M	362.2M	361M	530.3M	502.1M	674.6M	605.3M	38.3M	83.5M	34.8M	0.0	6M
Deferred Revenue	9.2M	7.2M	6.5M	5.9M	8.6M	6.9M	8.5M	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	-53.6M	0.0	0.0	0.0	0.0	0.0	0.0	-38.3M	-83.5M	-34.8M	0.0	-6M
Total Current Liabilities	336.7M	462.5M	419.4M	585M	556.8M	724.5M	663.8M	0.0	0.0	0.0	0.0	0.0
NON-CURRENT LIABILITIES
Long Term Debt	722M	1.1B	809M	578.7M	584.2M	542.7M	528.3M	1B	858M	589.4M	576.2M	62.6M
Deferred Revenue (Non-Current)	9.2M	7.2M	6.5M	5.9M	8.6M	6.9M	8.5M	7M	6.2M	5M	4.4M	3M
Other Non-Current Liabilities	10.7M	6.1M	8.2M	9.4M	24.8M	42.3M	8.8M	-1.1B	-883M	-614.6M	-603.6M	-65.6M
Total Non-Current Liabilities	770.6M	1.2B	825.2M	596.2M	617.2M	601M	554.8M	0.0	0.0	0.0	0.0	0.0
Other Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1B	1B	689.4M	670.2M	125.5M
Capital Lease Obligations	28.7M	12.2M	8M	8.1M	8.1M	9.2M	9.1M	0.0	0.0	0.0	0.0	0.0
Total Liabilities	1.1B	1.3B	1.2B	1.2B	1.2B	1.3B	1.2B	1.1B	1B	689.4M	670.2M	125.5M
SHAREHOLDERS' EQUITY
Preferred Stock	73K	76K	76K	76K	76K	16K	16K	0.0	0.0	0.0	0.0	0.0
Common Stock	1.1M	1.1M	1.1M	1.1M	993K	938K	923K	919K	910K	894K	861K	837K
Additional Paid-In Capital	2.5B	2.5B	2.5B	2.4B	2.3B	2.1B	2.1B	2B	2B	2B	1.9B	1.9B
Retained Earnings	-1.9B	-1.9B	-1.6B	-1.5B	-1.3B	-1.1B	-971.2M	-804.3M	-665M	-486.6M	-316.3M	-129.4M
Accumulated Other Comprehensive Income/Loss	5.6M	16.6M	23.5M	36.9M	-14.3M	-39.7M	-7M	0.0	0.0	0.0	0.0	463K
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	-7M	4.6M	2.5M	0.0	-6K	0.0
Total Stockholders' Equity	600.1M	684.6M	894.2M	992.6M	1B	957M	1.1B	1.2B	1.3B	1.5B	1.6B	1.7B
Total Equity	604.5M	690.1M	900.6M	999.2M	1B	961.4M	1.1B	1.2B	1.4B	1.5B	1.6B	1.7B
Minority Interest	4.5M	5.6M	6.4M	6.6M	6.7M	4.4M	5.4M	7.8M	8.5M	8.9M	9.7M	10.1M
SUMMARY
Total Liabilities & Equity	1.7B	1.9B	2.1B	2.2B	2.2B	2.3B	2.3B	2.4B	2.4B	2.2B	2.3B	1.9B
Total Investments	1.5B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Debt	1.1B	1.1B	1.2B	1.1B	1.1B	1.2B	1.1B	1.1B	960.3M	644.4M	599.2M	68.6M
Net Debt	978.9M	1.1B	1.1B	1.1B	1B	1.2B	1B	991.2M	857.7M	611.3M	570.1M	-115.8M
Shares Outstanding	28,297,355	28,297,355	28,297,355	28,297,355	28,297,355	28,297,355	28,297,355	28,297,355	28,297,355	28,297,355	28,297,355	28,297,355

SEC Filings

NHPAP - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 18, 2026	May 18, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 15, 2026	May 15, 2026	2026	View Filing
8-K/A 8-K/A 2026 (Amended) N/A	May 15, 2026	May 04, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 14, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 13, 2026	May 13, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 08, 2026	May 04, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 01, 2026	April 30, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 27, 2026	April 21, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 13, 2026	April 10, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 31, 2026	May 15, 2026	2026	View Filing

Showing 1 to 10 of 292 filings

Related Guides

Blog Categories

Continue your NHPAP research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.